Morishita Jintan Co., Ltd. AI Stock Analysis
Want to see JP:4524 full AI Analyst Report?
Morishita Jintan Co., Ltd. (4524) AI Stock Analysis
Morishita Jintan Co., Ltd.
(TSE/TYO:4524)
The score is driven primarily by solid underlying financial stability (notably a conservative balance sheet) offset by uneven cash conversion and a recent revenue dip. Technicals are supportive with a clear uptrend, though near-overbought signals limit upside in the near term. Valuation adds support via a moderate P/E and a ~2.9% dividend yield.
Morishita Jintan Co., Ltd. (4524) vs. iShares MSCI Japan ETF (EWJ)
- Market Cap
- JPY 9.06B
- Dividend Yield
- 2.95%
- Average Volume (3M)
- 1,600
- Price to Earnings (P/E)
- 10.3
- Beta (1Y)
- 0.32
- Revenue Growth
- -0.47%
- EPS Growth
- 50.82%
- Country
- Japan
- Employees
- 359
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Drug Manufacturers - Specialty & Generic
Morishita Jintan Co., Ltd. Business Overview & Revenue Model
Company Description
Morishita Jintan Co., Ltd. is a Japanese enterprise that manufactures and distributes a diverse array of products, encompassing pharmaceuticals, quasi-pharmaceuticals, medical devices, and food items. The company's operations are divided into two mai...
How the Company Makes Money
null
Morishita Jintan Co., Ltd. Financial Statement Overview
Summary
Financials are generally stable with a strong balance sheet (low leverage and solid equity), but the overall picture is held back by cash-flow inconsistency (volatile/near-breakeven free cash flow) and a modest revenue decline in 2026.
Income Statement
66PositiveBalance Sheet
78PositiveCash Flow
57Neutral| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 12.82B | 12.69B | 12.77B | 12.41B | 11.36B | 9.56B |
| Gross Profit | 6.23B | 5.93B | 5.79B | 6.00B | 5.31B | 4.88B |
| EBITDA | 1.54B | 1.29B | 1.36B | 1.29B | 1.25B | 977.00M |
| Net Income | 789.00M | 628.00M | 547.00M | 697.00M | 491.00M | 283.00M |
Balance Sheet | ||||||
| Total Assets | 18.62B | 18.62B | 17.90B | 17.18B | 16.10B | 14.48B |
| Cash, Cash Equivalents and Short-Term Investments | 1.52B | 1.83B | 1.94B | 1.09B | 2.41B | 2.14B |
| Total Debt | 1.75B | 1.76B | 1.36B | 270.00M | 469.00M | 749.00M |
| Total Liabilities | 5.65B | 5.64B | 5.74B | 5.04B | 4.71B | 4.02B |
| Stockholders Equity | 12.97B | 12.98B | 12.15B | 12.14B | 11.39B | 10.46B |
Cash Flow | ||||||
| Free Cash Flow | 0 | 18.00M | 69.00M | -455.00M | 715.00M | -159.00M |
| Operating Cash Flow | 0 | 1.15B | 669.00M | 196.00M | 1.18B | 543.00M |
| Investing Cash Flow | 0 | -1.23B | -701.00M | -1.15B | -474.00M | -463.00M |
| Financing Cash Flow | 0 | -30.00M | 880.00M | -362.00M | -433.00M | -645.00M |
Morishita Jintan Co., Ltd. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4524, the sentiment is Neutral. The current price of 2202.00 is above the 20-day moving average (MA) of 2198.45, below the 50-day MA of 2220.30, and below the 200-day MA of 2209.67, indicating a neutral trend. The MACD of -3.88 indicates Negative momentum. The RSI at 49.03 is Neutral, neither overbought nor oversold. The STOCH value of 76.58 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:4524.
Morishita Jintan Co., Ltd. Peers Comparison
Overall Rating
JP:292971Outperform
JP:454070Outperform
JP:452469Neutral
JP:453864Neutral
JP:451245Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 71Outperform | JPY 16.25B | 8.21 | ― | 3.91% | -3.12% | 406.78% | |
| 70Outperform | JPY 305.65B | 9.35 | 9.84% | 3.95% | 13.32% | 17.39% | |
| 69Neutral | JPY 8.98B | 10.28 | ― | 2.95% | -0.47% | 50.82% | |
| 64Neutral | JPY 19.25B | 8.43 | ― | 4.10% | 2.29% | ― | |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| 45Neutral | JPY 10.07B | 55.88 | ― | 1.21% | 23.41% | 149.71% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JP:4524 | Morishita Jintan Co., Ltd. | 2202.00 | 131.39 | 6.35% | |
| JP:4540 | Tsumura & Co | 3995.00 | 325.73 | 8.88% | |
| JP:2929 | Pharma Foods International Co., Ltd. | 561.00 | -196.06 | -25.90% | |
| JP:4512 | Wakamoto Pharmaceutical Co., Ltd. | 290.00 | 17.30 | 6.34% | |
| JP:4538 | Fuso Pharmaceutical Industries,Ltd. | 2194.00 | 121.93 | 5.88% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Aug 17, 2026
